NuVasive, Inc. (NuVasive), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, said that its executive vice president & chief financial officer (CFO) Kevin O'Boyle, is resigning to attend to personal and family obligations. O'Boyle plans to remain with the company until December 31, 2009 or potentially longer, to assist in the recruitment of his replacement and to effect an orderly transition.

The company said it is currently searching for a new CFO.

I have thoroughly enjoyed serving as part of the management team of NuVasive, helping to build the Company into a major player in the spine industry with a unique culture of Absolute Responsiveness, O’Boyle said. Unfortunately, personal obligations make a long term position as CFO of NuVasive extremely difficult to maintain. I would like to thank all NuVasive shareowners for making my time at NuVasive a remarkable one.

Alex Lukianov, chairman and chief executive officer, said, Kevin has been part of our executive team for the past 6 years, from fundraising as a private company, to our initial public offering, to helping build our corporate infrastructure for long term growth and continued market share gains. We thank him for his contributions to the Company and wish him well as he attends to important family and personal matters.

Lukianov continued, Our financial and business condition is vibrant and healthy as we continue to expand our presence in the market. We have begun the comprehensive search process to identify a new CFO and will be conducting a thorough review to identify the best possible leader to help take us to $1 billion in sales and beyond in concert with expanding profitability and an outstanding financial infrastructure.